The company is revolutionizing regenerative healthcare through innovation, clinical alignment, and GMP-grade excellence across Southeast Asia

SAN ANTONIO, Dec. 15, 2025 /PRNewswire/ — Frost & Sullivan is pleased to announce that MEDEZE Group Public Company Limited (MEDEZE) has been honored with the 2025 Southeast Asia Company of the Year Recognition in the stem cell banking and regenerative medicine industry for its outstanding achievements in innovation, regulatory leadership, and clinical alignment. This recognition highlights MEDEZE’s leadership in advancing the next generation of personalized healthcare solutions while maintaining the highest global standards in safety, technology, and compliance.

This recognition highlights MEDEZE’s leadership in advancing the next generation of personalized healthcare solutions while maintaining the highest global standards in safety, technology, and compliance.

Frost & Sullivan evaluates companies through a rigorous benchmarking process across two core dimensions: strategy effectiveness and strategy execution. MEDEZE excelled in both, demonstrating its ability to align strategic initiatives with market demand while executing them with precision and scale. “MEDEZE is redefining stem cell banking in Southeast Asia through full-spectrum, clinically aligned solutions, leveraging innovation, regulatory leadership, and GMP-grade infrastructure to lead the transition from cell preservation to personalized medical application,” said Unmesh Lal, Vice President, Healthcare & Life Sciences at Frost & Sullivan.

Driven by a long-term strategy focused on innovation, clinical readiness, and international expansion, MEDEZE has built one of the region’s most comprehensive and technologically advanced cell banking ecosystems. Its vertically integrated model—spanning biological material collection, diagnostics, cell processing, storage, expansion, and clinical application—ensures consistent quality, regulatory compliance, and scalability across Southeast Asia.

Innovation is central to MEDEZE’s success. Proprietary technologies, such as the AutoXpress System for fully automated cord blood processing and the Chibuya Robotic Stem Cell Culture System (the world’s first full-room cleanroom automation), enable therapeutic-grade manufacturing at scale. The company’s AI-powered Hair Follicle Restoration platform and exclusive NK cell diagnostic technologies from Japan demonstrate its ability to extend cell applications into clinical and aesthetic care.

MEDEZE’s commitment to international accreditation and operational excellence strengthens its leadership in regenerative medicine. It is the only Thai stem cell bank accredited by the US-based Association for the Advancement of Blood & Biotherapies (AABB) and holds ISO 9001 and ISO 22716 certifications. These accreditations reinforce the company’s compliance with the highest safety and quality standards across both therapeutic and wellness applications.

Supported by a network of over 260 hospital partners, including leading institutions such as Samitivej Hospital Group and Bangkok Hospital, MEDEZE plays a central role in Thailand’s ADMP Sandbox clinical program. Through ongoing trials in osteoarthritis, degenerative disc disease, skin rejuvenation, colorectal cancer, and immune enhancement, MEDEZE is positioned to become one of the first private companies in Southeast Asia to commercialize licensed cell therapies by 2026.

Frost & Sullivan commends MEDEZE for setting a new benchmark in competitive strategy, innovation, and market responsiveness. Its integrated operational model, financial strength, and commitment to sustainable growth exemplify leadership in biotechnology and position it at the forefront of Southeast Asia’s transition toward licensed regenerative therapies.

Each year, Frost & Sullivan presents the Company of the Year Recognition to an organization that demonstrates outstanding strategy development and execution, resulting in measurable improvements in market share, customer satisfaction, and competitive positioning. The recognition celebrates forward-thinking companies that are redefining their industries through innovation and growth excellence.

Frost & Sullivan Best Practices Recognition
Frost & Sullivan’s Best Practices Recognitions honor companies across regional and global markets that exhibit exceptional achievement and consistent excellence in areas such as leadership, technological innovation, customer experience, and strategic product development. Each recognition is the result of a rigorous analytical process in which Frost & Sullivan industry experts benchmark performance through comprehensive interviews, deep-dive analysis, and extensive secondary research. The goal is to identify true best-in-class organizations that are driving transformative growth and setting new industry standards.
Contact us: Start the discussion.

Contact:
Tarini Singh
E: Tarini.Singh@frost.com 

HANGZHOU, China, Dec. 15, 2025 /PRNewswire/ — China’s top international privately-owned enterprises represent a distinct and increasingly influential group within the global economy – companies whose international presence is defined less by export volume and more by embedded global operations, innovation capability and long-term responsibility.

Who, then, are these firms? The answer emerges from the newly released 2025 China’s Top 100 Most International Privately-Owned Enterprises, published by the Center for Chinese Multinationals (CCM) at Zhejiang University International Business School (ZIBS), in collaboration with the Cambridge Centre for Chinese Management and the Zheshang Institute.

Now in its fifth consecutive year, the ranking has evolved from a measurement exercise into a structured portrait of a new generation of globally active private enterprises. It assesses companies across four core dimensions – scale of internationalization, international organizational structure, international innovation, and international influence. Rather than asking how much these firms export, the 2025 edition asks how they operate globally – and what distinguishes them as global business actors.

A Structural Shift: Globalization Beyond Exports

The Top 100 companies generated a combined RMB 3.98 trillion (USD ~560 billion) in overseas revenue, accounting for 33.3% of their total revenue, with average overseas revenue reaching RMB 39.78 billion per company. Collectively, they form a group for which international markets are no longer peripheral, but structurally embedded in core business operations. All ranked firms have established overseas subsidiaries, operating across an average of 18 countries and regions.

Overseas footprints are most concentrated in East Asia (79 companies), North America (64), Southeast Asia (63) and Europe (58) – a pattern that reflects not opportunistic expansion, but deliberate global positioning.

Together, these figures suggest that Chinese private enterprises are moving decisively beyond cross-border trade. Increasingly, they are embedding themselves in local markets – through regional headquarters, localized manufacturing, service networks and, in some cases, overseas R&D – signaling a shift from transactional globalization to long-term market integration.

Manufacturing as the Backbone of Global Reach

Manufacturing remains the anchor of this global expansion. Eighty-four of the Top 100 companies come from manufacturing industries, underscoring China’s enduring strengths as a global manufacturing powerhouse.

At a more granular level, three sectors stand out: computer, communications and electronic equipment manufacturing (25 companies); electrical machinery and equipment (20); and non-ferrous metal smelting and rolling (8). Their prominence highlights the growing international competitiveness of China’s private manufacturers in advanced equipment, electronics and high-value industrial systems – areas where success depends on engineering depth, supply-chain coordination and sustained innovation, rather than scale alone.

Regional Clusters Highlight the Yangtze River Delta’s Leadership

The Top 100 enterprises span 21 provinces, autonomous regions and municipalities across China. Zhejiang and Guangdong lead with 22 companies each, followed by Jiangsu and Shandong (8 each), and Beijing and Shanghai (6 each).

This clustering effect is particularly pronounced in the Yangtze River Delta, which has emerged as the most important domestic hub supporting the internationalization of private enterprises – demonstrating how dense industrial ecosystems, innovation infrastructure and global connectivity at home continue to shape firms’ ability to compete abroad.

Innovation as a Prerequisite, Not an Option

Behind global expansion lies sustained investment in innovation. In 2024, the Top 100 companies recorded total R&D investment of RMB 456 billion, averaging RMB 4.6 billion per firm, while collectively holding 60,935 patents.

These figures align with broader national trends: private enterprises now account for more than 50% of China’s total R&D expenditure and over 70% of technological innovation outcomes. Among the most internationalized firms, innovation is no longer a supporting function – it is a foundational condition for sustaining global competitiveness, particularly in technology- and capital-intensive industries.

From Market Presence to Global Influence

The most subtle, yet consequential, transformation captured by the ranking lies in influence. Internationalization is no longer measured solely by market access, but increasingly by visibility, credibility and responsibility.

The Top 100 companies recorded more than 816 million global online searches over the past year, reflecting the rising visibility of Chinese brands among global consumers. At the same time, their average ESG score of 80.65 points to a deeper integration of environmental, social and governance considerations into global operations.

Leading firms are treating ESG not as a reporting obligation, but as a source of competitive advantage – investing in green manufacturing overseas, advancing supply-chain decarbonization and building long-term partnerships with local communities. In this sense, the most internationalized private enterprises are distinguished not only by where they operate, but by how they are perceived and accepted in global markets.

Defining a New Profile of Global Enterprise

Taken together, the 2025 China’s Top 100 Most International Privately-Owned Enterprises answers a central question: who are China’s most international private companies today? They are no longer defined primarily as exporters or cost-driven manufacturers. They are becoming system builders, innovators and responsible global participants.

This evolving profile reflects a broader transformation in global business itself, offering valuable insights into how emerging-market enterprises can build sustainable global presence – not merely through scale, but through structure, innovation and legitimacy – in an increasingly complex international environment.

About the Center for Chinese Multinationals (CCM):

Established in Nov. 2022, the Center for Chinese Multinationals (CCM) at Zhejiang University International Business School (ZIBS) aims at becoming a leading research center on the internationalization of Chinese private enterprises and works to strengthen the bridge between government, academia and industry through innovative academic initiatives and through continuous contact with business leaders, regulators and entrepreneurs. Learn more about the center: Sally Shen, sallyshen@zju.edu.cn; Hengyu Lu, hengyulu@intl.zju.edu.cn.

TAIPEI, Dec. 15, 2025 /PRNewswire/ — Graid Technology Inc. announced today that it has been honored with both the Top 10 Enterprises of the Year and the Innovative Design of the Year Award at the 19^th Taiwan Golden Torch Awards, recognizing the company’s excellence in corporate performance and technological innovation.

The Golden Torch Awards are organized by the Outstanding Enterprise Manager Association (OEMA), an organization established in 1994 to promote professional business management and industrial advancement. The awards are widely regarded across the Asia-Pacific region for their rigorous evaluation standards and strong industry credibility.

Since its inception, Graid Technology has focused on high-performance storage acceleration and data protection technologies, serving AI, HPC, and data center environments worldwide. Through disciplined operations and sustained investment in research and development, the company has successfully commercialized advanced storage technologies into scalable, production-ready solutions. These solutions enable enterprises to address increasing requirements for performance, reliability, scalability, and ESG-related efficiency, aligning closely with the evaluation criteria of the Top 10 Enterprises of the Year.

In the area of innovation and product design, Graid Technology was recognized for its industry-leading GPU-based NVMe RAID architecture. By adopting an Out-of-Path design, the solution addresses traditional RAID I/O bottlenecks, enabling 4x to 10x improvements in read and write performance while maintaining data protection and system stability. The technology has been deployed across AI training, real-time inference, and high-performance computing workloads, demonstrating both practical market adoption and forward-looking design principles consistent with the Innovative Design of the Year Award.

According to the company, the dual awards reflect recognition of Graid Technology’s long-term commitment to innovation and global market development, while reaffirming the alignment of its technology roadmap with evolving industry needs. Going forward, Graid Technology will continue to strengthen its high-performance storage and data protection portfolio and collaborate with global partners to deliver reliable, next-generation computing and storage solutions.

CHENGDU, China, Dec. 15, 2025 /PRNewswire/ — Recently, LivingPhoenix Regenerative Technologies has captured widespread attention with its world-first “Stable Triple-Helix Biomimetic Collagen” technology, making consecutive appearances at 12 high-level academic conferences in November. These events spanned aesthetic medicine, regenerative medicine, and personal care. Several academicians and industry experts have unanimously hailed the innovation as a mark of collagen R&D’s evolution from “animal extraction” and “genetic recombination” to “structural design.” Recognized as a revolutionary third-generation breakthrough,it is being celebrated as the “iPhone moment” for extracellular matrix research.

October 31 – At the 3rd Badachu Aesthetic Medicine Industry Forum, founder Qin Xingjiong systematically elaborated on the innovation pathway driven by compliance, receiving high praise from the industry. Subsequently, at the “2025 10th Medical Collagen Industry Academic Conference” under the honorary chairmanship of Academician Liao Wanqing of the Chinese Academy of Engineering-the founder delivered a report titled “Aqueous Polymer-Based Stable Triple-Helix Biomimetic Collagen.” Academician Zhang Qiqing of the Chinese Academy of Medical Sciences commented excellent.

November 7 – At the 2025 Scientists (International) Conference in Changsha, the founder presented a new paradigm of “Structure-Driven Application,”resonating with Nobel laureates and over 3,000 global professionals. On the same day, the Smartender Bouncy Bar made its global debut at the CIIE Sichuan Pavilion. Nearly 1,000 trial kits were distributed instantly, receiving enthusiastic feedback such as “Good! Younger!” and “This is a game-changer!” Chengdu Vice Mayor Chen Zhiyong visited the booth to encourage the company.

International Expansion: Livingphoenix has been invited to join as a Council Member of the Global Aesthetic Medicine and Health Organization. The team traveled to Indonesia to brief Mr. Jeffri Ardiyanto(Ministry of Health) on the technology’s core advantages—animal-free, ethical, and fully compliant with Islamic Halal requirements- receiving positive official feedback. The team was also granted an audience with a Presidential Special Envoy and Members of Parliament. At the MediCosme 2025 International Injectable Aesthetic Technology Innovation Conference, the founder chaired a forum. Professor Xiao Jianxi, a PhD supervisor at Lanzhou University, concluded: “Animal-derived collagen is ancient yet modern, recombinant collagen is youthful and vibrant, while biomimetic collagen represents the future.”

Science reaches new heights, industry conveys human warmth. Guided by its core principle of “Biomimetic Collagen + ECM Reconstruction,” Livingphoenix is advancing the vision of “Cell House — Where Regeneration Begins,” showcasing the power of “Created in China” to the world.

SEOUL, South Korea, Dec. 15, 2025 /PRNewswire/ — Medit, a global leader in 3D dental scanning solutions, announced the launch of “Medit’s 2025 End of Year Promotion,” a limited-time campaign delivering significant benefits to dental professionals worldwide. Dental professionals can learn more about the promotion details and encourage to leave their contact information at https://www.medit.com/medit-mobility-trade-up-promotion2025/. The promotion celebrates the debut of the Medit i900 Mobility, offering exclusive launch promotions alongside major upgrade opportunities across the Medit i900 family.

Exclusive Launch Benefits for Medit i900 Mobility

As part of the Medit i900 Mobility launch, Medit is introducing a special promotion that provides an enhanced mobility experience through added-value elements available only during the promotional period. This benefit is designed to support clinicians seeking a seamless and flexible mobile workflow.

Trade-In & Trade-Up to the Medit i900 Family

As part of the year-end celebration, Medit is also introducing a compelling Trade-In & Trade-Up program, enabling customers to upgrade to the Medit i900 family—one of the most advanced intraoral scanner lineups. This offer allows clinics to modernize their digital dentistry capabilities with industry-leading accuracy, speed, and usability while enjoying meaningful savings of up to 30%.

Limited-Time Promotion Through the End of 2025

This promotion is only available through the end of the year, offering dental professionals a rare opportunity to experience Medit’s latest innovations and upgrade their clinical workflows at exceptional value. All benefits are time-limited and will not be extended beyond the promotional period.

The Medit i900 Mobility is leading a new wave of innovation in the global dental industry as the first solution in digital dentistry to support an iPad-based workflow. In addition, the Medit i900 family has already gained strong popularity in clinical settings thanks to its lightweight design and exceptional scanning accuracy.

Dental professionals interested in upgrading their scanners or exploring Medit’s mobility-focused workflows are encouraged to visit https://www.medit.com/medit-mobility-trade-up-promotion2025/ to review eligibility, learn more about local availability, and submit their details for follow-up.

About Medit

Medit is a global provider of 3D intraoral scanners and digital dentistry solutions based on proprietary technology. The company enables collaborative workflows between dental clinics and labs through innovative hardware and software solutions. Headquartered in Seoul, South Korea, since 2000, Medit has a strong global presence through its offices in the Americas and Europe and a distributor network spanning over 100 countries. For more information and updates, visit www.medit.com.